Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]

Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite] Publisher Pubmed

Shadnoush M¹ ; Rabizadeh S² ; Esteghamati A² ; Nakhjavani M² ; Paridari NB³ ; Khoshabi M⁴ ; Rajab A² ; Ghaemi F⁵

Show Affiliations

1. Department of Clinical Nutrition, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Endocrinology and Metabolism Research Center, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
3. Non-Communicable Disease Treatment Group, Ministry of Health and Medical Education, Tehran, Iran
4. Department of Geospatial Information Systems, Center of Excellence in GIS, K.N. Toosi University of Technology, Tehran, Iran
5. Department of Transplantation and Disease Management, Ministry of Health and Medical Education, Tehran, Iran

Source: Eastern Mediterranean Health Journal Published:2022

Abstract

Background: Diabetes mellitus and hypertension are highly prevalent among patients with severe COVID-19. Aims: To study the mortality risk of COVID-19 infection in patients with type 2 diabetes and additive effect of hypertension and obesity in the Iranian population. Methods: This was a cross-sectional survey of the national COVID-19 registry from the Iranian Ministry of Health. The medical status of 22 002 patients with COVID-19 between 1 March and 30 April 2020 was analysed. Results: Patients with type 2 diabetes had a higher risk of mortality with an odds ratio (OR) of 1.67 [95% confidence interval (CI): 1.53–1.82, P < 0.001]. The risk of mortality was also high in patients with diabetes and hypertension, with an odds ratio of 1.76 (95% CI: 1.56–1.99, P < 0.001). The odds ratio of the risk of mortality in patients with diabetes, hypertension and obesity was 1.87 (95% CI: 1.35–2.58, P < 0.001). Conclusion: Type 2 diabetes, hypertension and obesity each predict mortality in Iranian patients with COVID-19, and when they are present together, patients have a greater risk of mortality. © World Health Organization (WHO) 2022.

Related Docs

View other Related Docs

1. Metabolic Syndrome and Covid-19; Clinical Complications and Challenges, Journal of Isfahan Medical School (2021)

2. Factors Associated With Mortality in Covid-19 Patients: A Systematic Review and Meta-Analysis, Iranian Journal of Public Health (2020)

3. Clinical and Epidemiological Features of Hospitalized Patients With Covid-19 in Hospitals of Tehran University of Medical Sciences, Frontiers in Emergency Medicine (2021)

4. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)

5. Covid-19 in Patients With Diabetes: Factors Associated With Worse Outcomes, Journal of Diabetes and Metabolic Disorders (2021)

6. Risk Indicators Associated With In-Hospital Mortality and Severity in Patients With Diabetes Mellitus and Confirmed or Clinically Suspected Covid-19, Journal of Diabetes and Metabolic Disorders (2021)

7. A Year of Experience With Covid-19 in Patients With Cancer: A Nationwide Study, Cancer Reports (2023)

8. Clinical Course and Outcome in Diabetic Patients With Covid-19, Immunopathologia Persa (2021)

Experts (# of related papers)

View all Related Experts

Bagher Larijani (4)

Ozra Tabatabaei-Malazy (3)

Style	Citing Format
MLA	Shadnoush M, et al.. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal, vol. 28, no. 3, 2022, pp. 221-224.
APA	Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F (2022). Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal, 28(3), 221-224.
Chicago	Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal 28, no. 3 (2022): 221-224.
Harvard	Shadnoush M et al. (2022) 'Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]', Eastern Mediterranean Health Journal, 28(3), pp. 221-224.
Vancouver	Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, et al.. Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal. 2022;28(3):221-224.
BibTex	@article{ author = {Shadnoush M and Rabizadeh S and Esteghamati A and Nakhjavani M and Paridari NB and Khoshabi M and Rajab A and Ghaemi F}, title = {Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]}, journal = {Eastern Mediterranean Health Journal}, volume = {28}, number = {3}, pages = {221-224}, year = {2022} }
RIS	TY - JOUR AU - Shadnoush M AU - Rabizadeh S AU - Esteghamati A AU - Nakhjavani M AU - Paridari NB AU - Khoshabi M AU - Rajab A AU - Ghaemi F TI - Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite] JO - Eastern Mediterranean Health Journal VL - 28 IS - 3 SP - 221 EP - 224 PY - 2022 ER -

Style

Citing Format

MLA

Shadnoush M, et al.. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal, vol. 28, no. 3, 2022, pp. 221-224.

APA

Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F (2022). Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal, 28(3), 221-224.

Chicago

Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal 28, no. 3 (2022): 221-224.

Harvard

Shadnoush M et al. (2022) 'Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]', Eastern Mediterranean Health Journal, 28(3), pp. 221-224.

Vancouver

Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, et al.. Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal. 2022;28(3):221-224.

BibTex

@article{ author = {Shadnoush M and Rabizadeh S and Esteghamati A and Nakhjavani M and Paridari NB and Khoshabi M and Rajab A and Ghaemi F}, title = {Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]}, journal = {Eastern Mediterranean Health Journal}, volume = {28}, number = {3}, pages = {221-224}, year = {2022} }

RIS

TY - JOUR
AU - Shadnoush M
AU - Rabizadeh S
AU - Esteghamati A
AU - Nakhjavani M
AU - Paridari NB
AU - Khoshabi M
AU - Rajab A
AU - Ghaemi F
TI - Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]
JO - Eastern Mediterranean Health Journal
VL - 28
IS - 3
SP - 221
EP - 224
PY - 2022
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract